EUROLAB
iso-10993-3-genotoxicity-testing
Biocompatibility Testing ASTM F1609 Evaluation of Surface ContaminationASTM F1904 Protein Adsorption TestingASTM F1980 Accelerated Aging of Medical DevicesASTM F2027 Cytotoxicity EvaluationASTM F2028 Evaluation of Sterilization ResidualsASTM F2052 Magnetically Induced DisplacementASTM F2080 Durability TestingASTM F2095 Evaluation of Additives in Medical PolymersASTM F2096 Particulate TestingASTM F2100 Medical Mask TestingASTM F2130 Endotoxin TestingASTM F2149 Antimicrobial Activity TestingASTM F2180 Sterilization Validation for HydrogelsASTM F2182 RF Induced Heating TestsASTM F2213 Evaluation of Magnetic Resonance CompatibilityASTM F2255 Acute Systemic ToxicityASTM F2273 Cytokine AnalysisASTM F2392 Implant Wear Debris AnalysisASTM F2458 Biofilm Formation TestingASTM F2459 Adhesion of Medical Device CoatingsASTM F2478 Safety Evaluation of PolymersASTM F2503 MR Safety LabelingASTM F2900 Testing of BiopolymersASTM F2941 Shelf Life TestingASTM F640 Extraction of Medical DevicesASTM F748 Evaluation of Medical Device BiocompatibilityASTM F756 Assessment of Hemolytic PropertiesEN ISO 10993-1 Biological Evaluation – Part 1EN ISO 10993-10 Sensitization TestingEN ISO 10993-11 Systemic ToxicityEN ISO 10993-5 Cytotoxicity TestingIEC 60601-1 Safety Requirements for Medical Electrical EquipmentISO 10993-1 Biological Evaluation of Medical DevicesISO 10993-10 Sensitization TestingISO 10993-11 Systemic Toxicity TestingISO 10993-12 Sample Preparation and Reference MaterialsISO 10993-13 Identification and Quantification of Degradation ProductsISO 10993-14 Degradation TestingISO 10993-15 Toxicokinetic StudyISO 10993-16 Toxicokinetic Study ProtocolISO 10993-17 Establishing Allowable LimitsISO 10993-18 Chemical Characterization TechniquesISO 10993-19 Biodegradation TestingISO 10993-2 Animal Welfare RequirementsISO 10993-20 Toxicology Data AnalysisISO 10993-21 Evaluation of Metals and AlloysISO 10993-22 Irradiation of Medical DevicesISO 10993-23 Biological Evaluation of ResidualsISO 10993-24 Toxicological Risk AssessmentISO 10993-25 Genotoxicity in Medical DevicesISO 10993-26 Immunotoxicology TestingISO 10993-27 Implant Material CharacterizationISO 10993-28 Evaluation of Metallic ImplantsISO 10993-29 Extraction ConditionsISO 10993-30 Analytical TechniquesISO 10993-31 Mutagenicity TestingISO 10993-32 Toxicity Tests for Medical PolymersISO 10993-33 Biological Evaluation of Degradation ProductsISO 10993-34 Evaluation of Chemical ResiduesISO 10993-35 Assessment of Extractables and LeachablesISO 10993-36 Nonclinical Safety EvaluationISO 10993-37 Evaluation of Cytokine ReleaseISO 10993-38 Endocrine Disruption TestingISO 10993-39 Evaluation of Material ExtractsISO 10993-4 Hemocompatibility TestingISO 10993-40 Evaluation of HemocompatibilityISO 10993-41 Toxicological Risk Assessment FrameworkISO 10993-42 Assessment of NanomaterialsISO 10993-5 Cytotoxicity TestingISO 10993-6 Local Effects after ImplantationISO 10993-7 Ethylene Oxide ResidualsISO 10993-9 Chemical CharacterizationISO 11135 Ethylene Oxide SterilizationISO 11137 Radiation SterilizationISO 11607 Packaging for Terminally Sterilized DevicesISO 11607-1 Packaging ValidationISO 11607-2 Packaging MaterialsISO 11607-3 Packaging TestingISO 11737-1 Sterilization ValidationISO 11737-2 Microbial Limit TestsISO 11737-3 Bioburden DeterminationISO 13408 Aseptic ProcessingISO 13408-1 Cleanroom TestingISO 13408-2 Aseptic Processing ValidationISO 13485 Quality Management Systems for Medical DevicesISO 13485 Risk Management IntegrationISO 13485-1 Quality System RequirementsISO 14117 Pulse Oximeter PerformanceISO 14155 Clinical Investigation StandardsISO 14155-1 Clinical Trial DesignISO 14155-2 Clinical Trial ConductISO 14160 Biocompatibility for Transfusion EquipmentISO 14161 Sterilization by Ethylene OxideISO 14161 Validation of Sterilization ProcessesISO 14630 Non-active Surgical ImplantsISO 14644 Cleanroom StandardsISO 14708 Active Implantable Medical DevicesISO 14708-3 Active Implantable Device TestingISO 14708-4 Implantable Device SafetyISO 14969 Quality Management for Sterile DevicesISO 14971 Risk Management DocumentationISO 14971 Risk Management for Medical DevicesISO 14971-2 Risk Management ReportingISO 15223 Medical Device SymbolsISO 17025 Testing Laboratory AccreditationISO 18113 Medical Device LabelingISO 18562 Biocompatibility of Breathing Gas PathwaysISO 22442 Medical Device Material TestingISO 25539 Cardiovascular ImplantsISO 25539-2 Coronary StentsISO 7405 Evaluation of Biocompatibility for DentistryISO 80369 Small-Bore ConnectorsUSP <87> Biological Reactivity TestsUSP <88> Tests for Plastic Materials

Comprehensive Guide to ISO 10993-3 Genotoxicity Testing Laboratory Testing Service Provided by Eurolab

Standard-Related Information

ISO 10993-3 is an international standard that specifies the requirements for in vitro genotoxicity testing of medical devices, including implantable devices, surgical instruments, and other equipment. This standard is part of a larger series of standards known as ISO 10993, which provides guidelines for the biological evaluation of medical devices.

Legal and Regulatory Framework

The legal and regulatory framework surrounding ISO 10993-3 Genotoxicity Testing testing is governed by various international and national standards, including:

  • ISO 10993-3:2014
  • ASTM F2847-09 (Reapproved 2020)
  • EN ISO 10993-3:2019
  • TSE EN ISO 10993-3:2019
  • EU Biocides Regulation (EU) No. 528/2012
  • These standards provide a framework for the testing and evaluation of medical devices to ensure their safety and efficacy.

    International and National Standards

    The development of international and national standards is overseen by organizations such as:

  • International Organization for Standardization (ISO)
  • American Society for Testing and Materials (ASTM)
  • European Committee for Standardization (CEN)
  • Turkish Standards Institution (TSE)
  • These organizations work together to develop and update standards, ensuring that they remain relevant and effective in protecting public health.

    Standard Evolution and Update

    Standards evolve over time as new technologies and research emerge. The ISO 10993 series is regularly updated to reflect the latest scientific understanding and regulatory requirements. This ensures that medical devices are tested and evaluated using the most up-to-date methods and techniques.

    Standard Numbers and Scope

    The following standard numbers and their scope are relevant to ISO 10993-3 Genotoxicity Testing testing:

  • ISO 10993-1:2018 - Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process
  • ISO 10993-2:2015 - Biological evaluation of medical devices Part 2: Sample preparation and reference materials
  • ISO 10993-3:2014 - Biological evaluation of medical devices Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • Standard Compliance Requirements

    Medical device manufacturers must comply with the relevant standards to ensure that their products meet regulatory requirements. Non-compliance can result in product recalls, financial penalties, or even withdrawal from the market.

    The following industries require ISO 10993-3 Genotoxicity Testing testing:

  • Medical devices
  • Pharmaceutical industry
  • Biotechnology industry
  • Food and beverage industry
  • These industries must comply with relevant standards to ensure that their products are safe for human use.

    Rationale for the Test

    ISO 10993-3 Genotoxicity Testing testing is necessary to evaluate the potential genotoxic effects of medical devices on living organisms. This test is critical in ensuring that medical devices do not cause harm or adverse reactions in humans.

    Consequences of Not Performing this Test

    Failure to conduct ISO 10993-3 Genotoxicity Testing testing can result in:

  • Product recalls
  • Financial penalties
  • Withdrawal from the market
  • Damage to reputation and brand image
  • Business and Technical Reasons for Conducting this Test

    Medical device manufacturers must perform ISO 10993-3 Genotoxicity Testing testing to ensure that their products meet regulatory requirements. This test is also necessary to protect public health and prevent adverse reactions.

    Quality Assurance and Quality Control Aspects

    Eurolab maintains a quality management system (QMS) that ensures the accuracy, reliability, and consistency of our ISO 10993-3 Genotoxicity Testing testing services.

    Competitive Advantages of Having this Testing Performed

    By performing ISO 10993-3 Genotoxicity Testing testing, medical device manufacturers can:

  • Ensure regulatory compliance
  • Protect public health and safety
  • Enhance product quality and reliability
  • Gain competitive advantage in the market
  • Cost-Benefit Analysis of Performing this Test

    The cost-benefit analysis of performing ISO 10993-3 Genotoxicity Testing testing is favorable, as it ensures regulatory compliance, protects public health, and enhances product quality.

    Test Conditions and Methodology

    The following sections describe the test conditions and methodology for conducting ISO 10993-3 Genotoxicity Testing testing:

    1. Testing Equipment and Instruments

    Cell culture equipment

    Incubators

    Microscopes

    Spectrophotometers

    2. Sample Preparation Procedures

    Sample collection and preparation

    Cell culture and treatment

    Measurement of genotoxic effects

    3. Testing Parameters and Conditions

    Concentration range

    Exposure duration

    Test duration

    4. Measurement and Analysis Methods

    Spectrophotometry

    Fluorescence microscopy

    Flow cytometry

    5. Calibration and Validation

    Eurolabs ISO 10993-3 Genotoxicity Testing testing services are conducted in accordance with the standard procedures outlined above.

    Quality Control Procedures

    Our quality control procedures ensure that all test samples are properly prepared, tested, and evaluated to ensure accurate results.

    Calibration and Validation

    All our equipment is regularly calibrated and validated to ensure accuracy and reliability of test results.

    We use state-of-the-art equipment and software to analyze test data and provide accurate and reliable results.

    Reporting and Documentation

    Test reports are provided in accordance with the standard requirements, including:

  • Test summary
  • Test protocol
  • Results
  • Conclusion
  • Certification and Accreditation

    Eurolab is certified by ISO 17025:2017 and accredited by the International Laboratory Accreditation Cooperation (ILAC) for our ISO 10993-3 Genotoxicity Testing testing services.

    This comprehensive guide to ISO 10993-3 Genotoxicity Testing laboratory testing service provided by Eurolab ensures that medical device manufacturers can meet regulatory requirements, protect public health and safety, and enhance product quality.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers